WADA Director General Olivier Niggli said: Every year, WADA leads an extensive consultation process concerning the Prohibited List, which involves some of the most qualified experts in the fields of science and medicine from around the world
In a syngeneic 4T1 breast cancer model, semaglutide increased intratumoral T-cell infiltration, promoted dendritic cell maturation, reduced FoxP3+ Tregs and enhanced CD8+ T-cell cytotoxicity despite showing no direct tumoricidal activity in vitro (108)
Edwards J, Howley P, Cohen IK
population, we found no evidence that GLP-1 RA use increases the risk of NAIONand in those with diabetes, we observed a lower risk
These results are important from a clinical perspective as a reduction in food intake accompanied by weight loss is a desirable outcome in an obese patient
I just worry that the headline/photo here is misleading